CTA Image
CTA Image

BRAIN-Biocatalysts Life Science Solutions:

Enzyme Solutions for Small Molecule APIs and Biologics

Home/ Sectors/ Pharmaceuticals
Your flexible end-to-end enzyme development and scale-up partner for small molecule API and biologics production
At BRAIN-Biocatalysts, we specialise in delivering innovative enzyme solutions tailored for the pharmaceutical industry. Our comprehensive capabilities enable our partners to accelerate drug development, safeguard their intellectual property, and seamlessly scale from enzyme discovery to full-scale production. Whether you're developing next-generation therapies or advancing pharmaceutical processes, we're here to ensure your success at every step of the journey. By leveraging the strengths of both companies, we simplify biocatalysis, delivering tailored, scalable solutions that ensure your product, your IP, and your future are fully supported.
BB LS logo bl
LS partner

End-to-end partner for enzyme solutions

End to end partner

The only company offering complete adaptable enzyme development and scale-up solutions to support the evolving need of the life science industry

LS sum nov

Your Product | Your IP | Your Future

Related Products
Amylase 11MDP
Rapid diges­tion of starch designed for use in dietary sup­ple­ment formulations.
Download Data Sheet Request a Sample
Catalase 929L
Removal of hydro­gen per­ox­ide used as a pro­cess­ing step to assist ster­il­i­sa­tion of food ingredients.
Download Data Sheet Request a Sample
Cellulase 13L
A high per­for­mance cel­lu­lase with beta-glu­canase and beta-glu­cosi­dase side activ­i­ties to con­tribute to a com­plete cel­lu­lose breakdown.
Download Data Sheet Request a Sample
DELTABREW® AA
Liq­uid con­cen­trat­ed heat sta­ble alpha-amy­lase for adjunct brew­ing, both GM and non-GM ver­sions available
More Information
DELTABREW® ALDC
Liq­uid ace­to­lac­tate decar­boxy­lase for faster beer maturation
More Information
DELTABREW® Attenumax
Liq­uid glu­coamy­lase for very high attenuation
More Information
DELTABREW® BAA
Liq­uid bac­te­r­i­al alpha-amy­lase for starch liquefaction
More Information
DELTABREW® BG
Liq­uid beta-glu­canase for vis­cos­i­ty reduc­tion and beer fil­tra­tion improve­ment, both GM and non-GM ver­sions available
More Information
Related Media
GOA Biocatalysts
11 Dec 2024
Biocatalysts Ltd and GOA Ventures announce long-term partnership to develop innovative enzymes for utilisation of seaweed
A long-term strategic collaboration aimed at accelerating sustainable protein and renewable energy solutions using seaweed, ultimately reducing the dependency on fossil-based raw materials and representing a significant advancement in eco-friendly valorisation of seaweed.
Read more
Group pic
25 Nov 2024
Food Ingredients Europe 2024: Key Highlights and Trends Shaping the Future of Food
As Food Ingredients Europe comes to a close for another year, we reflect back on the key trends from this year and what we can expect to see shaping the future of food ingredients.
Read more
Adobe Stock 642179533
18 Nov 2024
Biocatalysts Ltd Launches PlantPro™ enzyme range to address key challenges in the plant-based food industry
As consumer demand for plant-based products continues to rise, so do the challenges of creating foods that deliver on taste, texture, and functionality. This new brand will help our customers create standout products like plant-based beverages, dairy alternatives, meat substitutes, and cheese alternatives.
Read more
Adobe Stock 280503059
29 Oct 2024
Enhancing Enzyme Modified Dairy Ingredients with an Umami Boost
Glutamine is an amino acid found in protein -containing foods. Glutamine can be converted into glutamate and is one of the key factors in contributing a savoury umami taste sensation.
Read more
Shutterstock 175584830
29 Oct 2024
Biocatalysts Ltd Launches Innovative Enzymes Solution to Boost Umami Flavour in Dairy Ingredients
Unique enzyme solution designed to enhance umami flavours in dairy ingredients. This new product combines unique enzyme activities to create rich, savoury profiles to differentiate your dairy ingredients.
Read more
20 A1336
1 Oct 2024
BRAIN Biotech AG and Biocatalysts Ltd Launch a New Business Initiative to Revolutionise Enzyme Solutions within the Life Science Industry
Combining cutting-edge enzyme discovery, optimisation, and large-scale manufacturing to offer an end-to-end solution for the life sciences industry. BRAIN-Biocatalysts Life Science Solutions addresses critical gaps in the market, providing tailored enzyme solutions with a transparent IP strategy that ensures partners retain full control over their innovations.
Read more
Adobe Stock 171547572
Application Solution
Unlocking the benefits of plant oil hydrolysis
Free fatty acids, the fundamental building blocks in many sectors, can vary in chain length and degree of saturation, influencing their functionality and applications. However, the industry has long faced challenges in maximising the yield of free fatty acids while maintaining cost efficiency and environmental sustainability.
Read more
Adobe Stock 301708042
16 Sept 2024
Biocatalysts Ltd Launches Lipomod™ 70MDP - Setting A New Standard To Deliver Sustainable Solutions for Oleochemicals Industry with Maximal Production Efficiency
Achieve superior hydrolysis unseen in the market for breaking down plant-derived oils into valuable by-products like glycerol and fatty acids
Read more
1724910530995
30 Aug 2024
BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
BRAIN Biotech AG, a leading provider of integrated solutions for the biologisation of industry, today published its 9M results of FY2023/2024.
Read more
BRAIN Biotech Protein Engineering a684d3096d988b4015570ba64e80e48a
22 Aug 2024
BRAIN Biotech launches MetXtra™
Designed to establish and optimise biocatalytic processes, develop novel enzyme solutions and generate IP or FTO for customers, the cutting edge technologies of MetXtra™ unlock the secrets of the unexplored sequence space.
Read more
C19 A1662
30 Jul 2024
Biocatalysts Ltd launches new "Plug & Produce" production strains significantly reducing scale-up time and cost
Developing enzyme and protein fermentation processes can be long and expensive and is often reliant on a single partner. Our proprietary "Plug & Produce" platform of microbial fermentation strains can bring product to market quicker, reduce cost and reduce supply chain risk.
Read more
Adobe Stock 230190183
23 Jul 2024
The Crucial Role of Phenylalanine Dehydrogenase in Detecting Phenylketonuria
Phenylketonuria (PKU) is genetic disorder resulting from a deficiency in the enzyme phenylalanine hydroxylase for the conversion of the amino acid, phenylalanine to tyrosine. This condition can cause phenylalanine accumulation in the blood and result in neurological damage if left untreated or undiagnosed. Read about the highly specific and sensitive enzymatic method for early detection of PKU.
Read more
Sign up to our newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.